Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARIAD Pharmaceuticals ARIA

Healthcare Biotechnology
"ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788."

Recent & Breaking News (NDAQ:ARIA)

ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency

Business Wire February 6, 2017

Watch These 10 Huge Put Purchases In Tuesday Trade

Benzinga.com  January 31, 2017

Watch These 10 Huge Put Purchases In Friday Trade

Benzinga.com  January 27, 2017

Takeda's Speculative Interest In Synergy Soothes Stomach Pains; Canaccord Says Buy

Benzinga.com  January 25, 2017

Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders

PR Newswire January 18, 2017

ARIAD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of ARIAD Pharmaceuticals, Inc. (ARIA) Over the Proposed Sale of the Company to Takeda Pharmaceutical Company Limited

PR Newswire January 13, 2017

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

Business Wire January 12, 2017

Harwood Feffer LLP Announces Investigation of ARIAD Pharmaceuticals, Inc.

PR Newswire January 9, 2017

Mid-Afternoon Market Update: Ariad Pharmaceuticals Surges On Acquisition News; Stage Stores Shares Slide

Benzinga.com  January 9, 2017

ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire January 9, 2017

ARIAD Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion

Business Wire January 9, 2017

Takeda to Acquire ARIAD Pharmaceuticals, Inc.

Business Wire January 9, 2017

Biotech Stocks Under Review -- Novavax, Gilead Sciences, ARIAD Pharma, and Exelixis

PR Newswire January 5, 2017

ARIAD to Present at the 35th Annual J.P. Morgan Healthcare Conference

Business Wire January 3, 2017

Biotech Stocks Head Into 2017 With Clinical Developments That Could Lead to Growth and Added Value

PR Newswire December 21, 2016

Mid-Day Market Update: Dave & Buster's Climbs On Upbeat Results; Sigma Designs Shares Slide

Benzinga.com  December 7, 2016

Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans

Benzinga.com  December 7, 2016

ARIAD’s Investigational Medicine Brigatinib Demonstrated 15.6 Month Systemic Median Progression-Free Survival in ALTA Study

Business Wire December 7, 2016

New Collaborations and Licensing Activities for Biotech/Pharma Industries Pick Up Pace Heading into 2017

PR Newswire December 6, 2016

ARIAD Announces Data Presentations at American Society of Hematology Meeting

Business Wire December 6, 2016